LENARD MALMIN: Open Payments
NPI 1255908489 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$328 in 17 payments from 13 companies in 2025. Trend: 2023 $192 · 2024 $471 · 2025 $328
Food & beverage: $328
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $48 |
| Corium, LLC | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Alkermes, Inc. | 1 | $24 |
| Tris Pharma Inc | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
Products named: FANAPT, AUSTEDO XR, Azstarys, COBENFY, LYBALVI, Dyanavel XR, INVEGA SUSTENNA, Qelbree.
Industry payments across ID — which companies pay providers there.
